1. Home
  2. TECX vs MSBI Comparison

TECX vs MSBI Comparison

Compare TECX & MSBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • MSBI
  • Stock Information
  • Founded
  • TECX 2019
  • MSBI 1881
  • Country
  • TECX United States
  • MSBI United States
  • Employees
  • TECX N/A
  • MSBI N/A
  • Industry
  • TECX
  • MSBI Major Banks
  • Sector
  • TECX
  • MSBI Finance
  • Exchange
  • TECX Nasdaq
  • MSBI Nasdaq
  • Market Cap
  • TECX 387.1M
  • MSBI 315.4M
  • IPO Year
  • TECX 2018
  • MSBI 2016
  • Fundamental
  • Price
  • TECX $18.92
  • MSBI $16.04
  • Analyst Decision
  • TECX Buy
  • MSBI Hold
  • Analyst Count
  • TECX 6
  • MSBI 3
  • Target Price
  • TECX $79.17
  • MSBI $18.67
  • AVG Volume (30 Days)
  • TECX 682.4K
  • MSBI 180.9K
  • Earning Date
  • TECX 11-06-2025
  • MSBI 10-30-2025
  • Dividend Yield
  • TECX N/A
  • MSBI 7.98%
  • EPS Growth
  • TECX N/A
  • MSBI N/A
  • EPS
  • TECX N/A
  • MSBI N/A
  • Revenue
  • TECX N/A
  • MSBI $210,718,000.00
  • Revenue This Year
  • TECX N/A
  • MSBI $27.04
  • Revenue Next Year
  • TECX N/A
  • MSBI N/A
  • P/E Ratio
  • TECX N/A
  • MSBI N/A
  • Revenue Growth
  • TECX N/A
  • MSBI N/A
  • 52 Week Low
  • TECX $13.70
  • MSBI $14.24
  • 52 Week High
  • TECX $61.07
  • MSBI $28.08
  • Technical
  • Relative Strength Index (RSI)
  • TECX 55.49
  • MSBI 46.36
  • Support Level
  • TECX $18.49
  • MSBI $15.87
  • Resistance Level
  • TECX $20.39
  • MSBI $16.39
  • Average True Range (ATR)
  • TECX 2.22
  • MSBI 0.59
  • MACD
  • TECX 0.14
  • MSBI 0.05
  • Stochastic Oscillator
  • TECX 31.09
  • MSBI 62.59

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

Share on Social Networks: